Clorox Co (CLX) Research Coverage Started at JPMorgan Chase & Co.

JPMorgan Chase & Co. began coverage on shares of Clorox Co (NYSE:CLX) in a research note issued to investors on Tuesday morning. The firm issued a neutral rating and a $136.00 target price on the stock.

CLX has been the subject of a number of other reports. Zacks Investment Research upgraded Clorox from a strong sell rating to a hold rating in a research note on Tuesday, January 3rd. B. Riley reiterated a neutral rating and issued a $125.00 price target on shares of Clorox in a research note on Monday, February 6th. Barclays PLC set a $140.00 price target on Clorox and gave the company a hold rating in a research note on Saturday, February 18th. Morgan Stanley upgraded Clorox from an underweight rating to an equal weight rating and set a $112.00 price target for the company in a research note on Friday, December 16th. They noted that the move was a valuation call. Finally, BMO Capital Markets began coverage on Clorox in a research note on Thursday, December 15th. They issued an outperform rating and a $136.00 price target for the company. Eleven analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. Clorox has an average rating of Hold and a consensus target price of $131.82.

Analyst Recommendations for Clorox (NYSE:CLX)

Clorox (NYSE:CLX) opened at 137.81 on Tuesday. Clorox has a 12-month low of $111.24 and a 12-month high of $140.47. The company has a market capitalization of $17.68 billion, a price-to-earnings ratio of 27.64 and a beta of 0.32. The firm’s 50-day moving average price is $134.10 and its 200 day moving average price is $123.44.

Clorox (NYSE:CLX) last announced its quarterly earnings results on Friday, February 3rd. The company reported $1.25 EPS for the quarter, beating the Zacks’ consensus estimate of $1.22 by $0.03. Clorox had a return on equity of 239.42% and a net margin of 11.15%. The company earned $1.41 billion during the quarter, compared to analysts’ expectations of $1.41 billion. During the same period in the prior year, the company earned $1.14 EPS. Clorox’s revenue was up 4.5% compared to the same quarter last year. On average, analysts expect that Clorox will post $5.34 earnings per share for the current year.

TRADEMARK VIOLATION NOTICE: “Clorox Co (CLX) Research Coverage Started at JPMorgan Chase & Co.” was first published by Mideast Time and is owned by of Mideast Time. If you are accessing this piece on another domain, it was illegally stolen and reposted in violation of United States & international trademark & copyright laws. The original version of this piece can be accessed at https://www.mideasttime.com/clorox-co-clx-research-coverage-started-at-jpmorgan-chase-co/1589016.html.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 5th. Investors of record on Wednesday, April 19th will be issued a $0.80 dividend. The ex-dividend date of this dividend is Monday, April 17th. This represents a $3.20 dividend on an annualized basis and a yield of 2.32%. Clorox’s payout ratio is 64.13%.

A number of hedge funds have recently bought and sold shares of CLX. Salem Investment Counselors Inc. bought a new stake in Clorox during the third quarter worth $100,000. Valley National Advisers Inc. increased its stake in Clorox by 0.5% in the third quarter. Valley National Advisers Inc. now owns 849 shares of the company’s stock worth $106,000 after buying an additional 4 shares during the last quarter. Bartlett & Co. LLC increased its stake in Clorox by 13.8% in the third quarter. Bartlett & Co. LLC now owns 865 shares of the company’s stock worth $108,000 after buying an additional 105 shares during the last quarter. Mascoma Wealth Management LLC bought a new stake in Clorox during the fourth quarter worth $104,000. Finally, Van Hulzen Asset Management LLC bought a new stake in Clorox during the third quarter worth $113,000. Institutional investors and hedge funds own 70.14% of the company’s stock.

Clorox Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

5 Day Chart for NYSE:CLX

Receive News & Ratings for Clorox Co Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Co and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply

 
© 2006-2017 Mideast Time.